SG Americas Securities LLC Raises Position in The Clorox Company $CLX

SG Americas Securities LLC increased its position in shares of The Clorox Company (NYSE:CLX) by 13.2% during the 3rd quarter, Holdings Channel reports. The firm owned 157,260 shares of the company’s stock after purchasing an additional 18,340 shares during the quarter. SG Americas Securities LLC’s holdings in Clorox were worth $19,390,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Brown Lisle Cummings Inc. increased its position in shares of Clorox by 4.3% during the second quarter. Brown Lisle Cummings Inc. now owns 2,136 shares of the company’s stock valued at $256,000 after acquiring an additional 89 shares during the last quarter. American National Bank & Trust grew its position in Clorox by 69.5% during the second quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after buying an additional 89 shares during the period. Savvy Advisors Inc. increased its holdings in Clorox by 1.4% during the second quarter. Savvy Advisors Inc. now owns 6,395 shares of the company’s stock worth $768,000 after buying an additional 91 shares during the last quarter. Canandaigua National Bank & Trust Co. raised its position in Clorox by 0.8% in the third quarter. Canandaigua National Bank & Trust Co. now owns 11,196 shares of the company’s stock worth $1,380,000 after acquiring an additional 94 shares during the period. Finally, State of Michigan Retirement System boosted its stake in Clorox by 0.3% in the second quarter. State of Michigan Retirement System now owns 33,551 shares of the company’s stock valued at $4,028,000 after acquiring an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

NYSE:CLX opened at $104.24 on Friday. The business’s 50-day moving average price is $103.13 and its two-hundred day moving average price is $115.78. The Clorox Company has a twelve month low of $96.66 and a twelve month high of $164.22. The stock has a market cap of $12.72 billion, a P/E ratio of 16.36, a PEG ratio of 0.50 and a beta of 0.58. The company has a quick ratio of 0.50, a current ratio of 0.76 and a debt-to-equity ratio of 18.01.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. During the same quarter in the previous year, the firm earned $1.86 earnings per share. Clorox’s revenue was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be issued a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date is Wednesday, January 28th. Clorox’s dividend payout ratio is presently 77.86%.

Insider Activity at Clorox

In other news, Director Pierre R. Breber acquired 4,000 shares of the firm’s stock in a transaction that occurred on Friday, November 21st. The shares were bought at an average cost of $104.13 per share, with a total value of $416,520.00. Following the acquisition, the director owned 13,000 shares in the company, valued at approximately $1,353,690. This represents a 44.44% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.63% of the company’s stock.

Analyst Ratings Changes

A number of analysts have issued reports on CLX shares. Jefferies Financial Group reissued a “buy” rating and issued a $152.00 target price on shares of Clorox in a research report on Tuesday, November 4th. Wells Fargo & Company cut their target price on shares of Clorox from $117.00 to $108.00 and set an “equal weight” rating for the company in a research report on Monday. Morgan Stanley dropped their price target on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Clorox from $128.00 to $121.00 and set a “hold” rating for the company in a research note on Tuesday, November 4th. Finally, UBS Group set a $119.00 target price on Clorox and gave the stock a “neutral” rating in a research report on Tuesday, November 4th. One equities research analyst has rated the stock with a Buy rating, fourteen have assigned a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Reduce” and an average target price of $122.88.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.